Answers are grounded in this paper and cite their sources.
Based on plasma levels determined with a radioreceptor assay and following a single oral (50 micrograms/kg) and intravenous (5 micrograms/kg) administration of glycopyrrolate in six healthy children operated twice during a several weeks period, a negligible and variable oral bioavailability was found (3.3; 1.3-13.3%) (median;range). No significant changes in heart rate after oral or intravenous administration of the drug could be seen. Oral glycopyrrolate appears to have no place in paediatric premedication.
No takes yet. Share an insight, caveat, or question.
Rautakorpi et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: